Rainer Endermann
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 7
- Microbiology top 2%
- Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 8
- Antibiotics Pharmacokinetics and Efficacy 8
- Organic Chemistry top 5%
- Synthesis and biological activity 4
- Synthetic Organic Chemistry Methods 4
- Infectious Diseases top 5%
-
- Chemical Synthesis and Analysis 8
- Cancer therapeutics and mechanisms 4
-
- Bacterial Genetics and Biotechnology 4
- Co-authors
- Harald LabischinskiSuk Young ChoK. C. NicolaouNicolas WinssingerRobert HughesSiegfried RaddatzUwe PetersenA. Dalhoff
- Journals
- FEBS Letters (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- GermanyUnited StatesSingapore
In The Last Decade
Rainer Endermann
31 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 292
- Microbiology 176
- Pharmacology 451
- Organic Chemistry 659
- Infectious Diseases 273
Countries citing papers authored by Rainer Endermann
This map shows the geographic impact of Rainer Endermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Endermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Endermann more than expected).
Fields of papers citing papers by Rainer Endermann
This network shows the impact of papers produced by Rainer Endermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Endermann. The network helps show where Rainer Endermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rainer Endermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 63 | |
| 2 | Pharmacokinetics (PK) and In Vivo Efficacy of Oral Finafloxacin (FIN) and Comparators in Rodent Models of Systemic Infection | 2008 | 2 |
| 3 | In Vivo Efficacy of Finafloxacin (FIN) in Difficult to Treat Animal Models of Infection | 2008 | 1 |
| 4 | 2008 | 7 | |
| 5 | 2006 | 49 | |
| 6 | 2006 | 75 | |
| 7 | 2005 | 384 | |
| 8 | 2003 | 58 | |
| 9 | 2003 | 28 | |
| 10 | 2003 | 1 | |
| 11 | 2002 | 23 | |
| 12 | 2002 | 80 | |
| 13 | 2001 | 97 | |
| 14 | 2001 | 57 | |
| 15 | 2000 | 118 | |
| 16 | 1999 | 62 | |
| 17 | 1996 | 153 | |
| 18 | 1993 | 9 | |
| 19 | 1992 | 10 | |
| 20 | 1979 | 12 |
About Rainer Endermann
Rainer Endermann is a scholar working on Molecular Medicine, Pharmacology, Applied Microbiology and Biotechnology, Microbiology and Organic Chemistry, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (8 papers), Microbial Natural Products and Biosynthesis (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (7 papers), Synthesis and biological activity (4 papers), Synthetic Organic Chemistry Methods (4 papers), Cancer therapeutics and mechanisms (4 papers) and Bacterial Genetics and Biotechnology (4 papers). The work is most often cited by research in Molecular Medicine (292 citations), Microbiology (176 citations), Pharmacology (451 citations), Organic Chemistry (659 citations) and Infectious Diseases (273 citations). Rainer Endermann has collaborated with scholars based in Germany, United States and Singapore. Frequent co-authors include Harald Labischinski, Suk Young Cho, K. C. Nicolaou, Nicolas Winssinger, Robert Hughes, Siegfried Raddatz, Uwe Petersen, A. Dalhoff, Hein‐Peter Kroll and Heike Brötz‐Oesterhelt. Their work appears in journals such as FEBS Letters, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Chemotherapy and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.